This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Connecticut Children's and Texas Neonatal-Perinatal Review Corporation. Connecticut Children’s is accredited by the ACCME to provide continuing medical education for physicians. Connecticut Children's designates this live activity for a maximum of 44.75 AMA PRA Category 1 Credits™. Physicians should claim only credits commensurate with the extent of their participation in the various activities.
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 44.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
All faculty participating in Continuing Medical Education activities sponsored by Connecticut Children’s are required to disclose to the program audience any actual or perceived conflict of interest related to the content of their presentation. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content. Fernando Moya, MD has a financial relationship with Mead Johnson Nutrition as a speaker on the speaker bureau and does contracted research. Camilia R. Martin, MD, MS has a financial relationship with Vitara Biomedical, LactaLogics, Inc., and Plakous Therapeutics, Inc as an Advisory Committee Member. She is a consultant for Infant Bacterial Therapeutics and Baxter International. She was a speaker for Baxter International, completed research for Mead Johnson Nutrition, and performed expert testimony for Winston & Strawn/Abbott Nutrition. James Moore, MD, Ph.D. was a speaker for Chiesi, USA Inc., and Ravi Patel, MD, MSc was an advisory committee member for Noveome. Andrew Dylag, MD was a speaker for Chiesi USA Inc., and Martin Keszler, MD teaches for Draeger Medical. Michael D Weiss, MD is a consultant for Chiesi, USA Inc. James L. Wynn, MD is was a consultant for Inotrem. The additional planners, activity director and speaker(s) do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. All relevant financial relationships have been mitigated according to the ACCME guidelines.
Ravi Patel, MD, MSc has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Presentation will discuss use of probiotics, which have not been approved by the FDA for the prevention of neonatal diseases. Dara Brodsky, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: I will be discussing medications that are used in NICUs but not FDA-approved. These are: dopamine, dobutamine, epinephrine, norepinephrine, hydrocortisone. Matthew Saxonhouse, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Use of UFH, LMWH, and rTPA in neonates.
Abbott, Millennium Medical Group, Mallinckrodt, Birthing the Magic Collaborative, NEC Society, Graham's Foundation, and Texas EMS, Trauma & Acute Care Foundation and Texas Perinatal Services are exhibitors for this event.
Support for this activity is gratefully acknowledged from Chiesi USA, Inc.
